Mario Annunziata
- Hematology top 2%
- Genetics top 5%
- Molecular Biology
- Public Health, Environmental and Occupational Health top 10%
- Oncology
- Co-authors
- Felicetto FerraraEttore Mariano SchiavoneSalvatore PalmieriGiuseppina MeleGiorgina SpecchiaMariacarla De SimoneFabrizio PaneLuigi Del Vecchio
- Topics
- Chronic Lymphocytic Leukemia Research (20 papers)Chronic Myeloid Leukemia Treatments (20 papers)Acute Myeloid Leukemia Research (19 papers)
- Cited by
- HematologyGeneticsRheumatology
- Partner nations
- ItalyUnited KingdomIndia
In The Last Decade
Mario Annunziata
49 papers receiving 760 citations
Peers
Comparison fields: 5 of 70
- Hematology 592
- Genetics 255
- Molecular Biology 202
- Public Health, Environmental and Occupational Health 146
- Oncology 141
Countries citing papers authored by Mario Annunziata
This map shows the geographic impact of Mario Annunziata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Annunziata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Annunziata more than expected).
Fields of papers citing papers by Mario Annunziata
This network shows the impact of papers produced by Mario Annunziata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Annunziata. The network helps show where Mario Annunziata may publish in the future.
Co-authorship network of co-authors of Mario Annunziata
This figure shows the co-authorship network connecting the top 25 collaborators of Mario Annunziata. A scholar is included among the top collaborators of Mario Annunziata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario Annunziata. Mario Annunziata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 9 | |
| 3 | 1 | |
| 4 | 15 | |
| 5 | 7 | |
| 6 | 39 | |
| 7 | 9 | |
| 8 | 17 | |
| 9 | 7 | |
| 10 | 14 | |
| 11 | 15 | |
| 12 | 30 | |
| 13 | 35 | |
| 14 | 20 | |
| 15 | 12 | |
| 16 | 24 | |
| 17 | 9 | |
| 18 | 32 | |
| 19 | Therapeutic options and treatment results for patients over 75 years of age with acute myeloid leukemia. | 31 |
| 20 | 17 |
About Mario Annunziata
Mario Annunziata is a scholar working on Hematology, Genetics and Rheumatology, having authored 51 papers that have together received 776 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (20 papers), Chronic Myeloid Leukemia Treatments (20 papers) and Acute Myeloid Leukemia Research (19 papers). The work is most often cited by research in Hematology (592 citations), Genetics (255 citations) and Rheumatology (108 citations). Mario Annunziata has collaborated with scholars based in Italy, United Kingdom and India. Frequent co-authors include Felicetto Ferrara, Ettore Mariano Schiavone, Salvatore Palmieri, Giuseppina Mele, Giorgina Specchia, Mariacarla De Simone, Fabrizio Pane, Luigi Del Vecchio, Barbara Pocali and Bruno Martino. Their work appears in journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.